Ronald Hafner 13D and 13G filings for NLS Pharmaceutics AG:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-06-24 4:57 pm Purchase |
2025-05-22 | 13D | NLS Pharmaceutics AG NLSP |
Ronald Hafner | 557,131 13.200% |
246,173 (+79.17%) |
Filing |
| 2024-11-21 4:01 pm Purchase |
2024-09-30 | 13G | NLS Pharmaceutics AG NLSP |
Ronald Hafner | 310,958 8.100% |
310,958 (New Position) |
Filing |